Skip to main content
Article thumbnail
Location of Repository

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder

By Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni and A Carlo Altamura
Topics: Expert Opinion
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2671777
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2002). A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.
    2. (2003). A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.
    3. (2005). A randomized, doubleblind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
    4. (1978). A rating scale for mania:reliability, validity and sensibility.
    5. (1999). Abordaje Actual de Los Trastornos Bipolares.
    6. (2005). Acute and continuation risperidone monotherapy in bipolar mania:a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
    7. (2003). Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate. Prog Neuropsychopharmacol Biol Psychiatry,
    8. Allen MH.2003. Treatment of agitation in bipolar disorder across life cycle.
    9. Altamura AC. 2006.Clinical variables related to antidepressant-induced mania in Bipolar Disorder. J Affect Disord.
    10. (2004). Antianxiety effects analysis of quetiapine in bipolar depression [abstract].
    11. (1999). Antipsychotic-induced weight gain :a comprehensive research synthesis.
    12. (2004). Aripiprazole in acute mania associated with bipolar I disorder.
    13. (2004). Atypical antipsychotics and metabolic dysregulation:evaluating the risk/benefit equation and improving the standard of care.
    14. (2004). Atypical antipsychotics and the relevance of glutamate and serotonin.
    15. (2002). Atypical antipsychotics in mood disorders.
    16. (2005). Atypical antipsychotics:newer options for mania and maintenance therapy.
    17. (2001). Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet,
    18. (2004). Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder:an open label study. Hum Psychopharmacol,
    19. (2004). Combination quetiapine therapy in the long-term treatment of patients with refractory bipolar I disorders [abstract]. The 157th Annual Meeting of the American Psychiatric Association.
    20. (2004). Comparative evaluation of olanzapine efficacy in the maintenance treatment of Bipolar Disorder.
    21. (1986). Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients.
    22. (2001). Current research on rapid cycling bipolar disorder and its treatment.
    23. (2004). Double-blind, placebocontrolled study of quetiapine in bipolar depression [poster]. 157th Annual Meeting of the American Psychiatric Association.
    24. (2003). Efficacy and tolerability of quetiapine in the treatment of bipolar disorder:preliminary evidence from 12-month open-label study.
    25. (2005). Efficacy of atypical antipsychotics in bipolar disorder.
    26. (2003). Efficacy of atypical antipsychotics in mood disorders.
    27. (2003). Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry,
    28. (2000). Efficacy of olanzapine in acute bipolar mania:a double-blind, placebo-controlled study.
    29. (2002). Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
    30. (2000). Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
    31. et al 2003. Quetiapine may induce mania:a case report.
    32. et al 2003. Quetiapine-induced mania (letter).
    33. Exp Ther,
    34. (1996). ICI 204, 636, an atypical antipsychotic:efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia.
    35. (1997). In vitro prediction of potential metabolic drug interaction for seroquel (quetiapine) [abstract]. The 150th American Psychiatric Association Annual Meeting.
    36. (2005). Long-term treatment of adjunctive quetiapine for bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry,
    37. (1998). Mania induced dy risperidone:dose related?
    38. (2003). Manic symptoms associated with quetiapine treatment.
    39. (1997). Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP):the CGI-BP. Psychiatry Res,
    40. (2001). Modulation of glutamate recetors in response to the novel antipsychotic olanzapine in rats.
    41. (2005). Mood stabilization in the treatment of bipolar disorder:focus on quetiapine.
    42. (1997). Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia:a comparison with haloperidol and placebo.
    43. (1999). Neurobiological models of recurrence in mood disorders.
    44. (2001). Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
    45. (2004). New medication treatment options for bipolar disorders. Acta Psychiatr Scand,
    46. (1998). Novel antipsychotics and new onset diabetes.
    47. (1996). Novel antipsychotics and the problem of clinical stabilization in schizophrenia:are they “stabilizers” rather than typical compounds? Int Clin Psychopharmacol,
    48. (2000). Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate:an openlabel trial in adolescents with psychotic disorders.
    49. (2004). Possibile induction of mania or hypomania by atypical antipsychotics:an update review of reported cases.
    50. (2002). Psychiatric Association.
    51. (2001). Quetiapine alone and added to mood-stabilizer for serious mood disorders.
    52. (2000). Quetiapine for treatment-resistant mania.
    53. (1999). Quetiapine fumarate (Seroquel). A new atypical antipsychotic. Drugs Today (Barc),
    54. (1997). Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry,
    55. (2005). Quetiapine monotherapy for mania associated with bipolar disorder :combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Med Res Opin,
    56. (2005). Quetiapine or haloperidol as monotherapy for bipolar mania:a 12-week, double-blind, randomized, parallel group, placebo-controlled trial.
    57. (2002). Quetiapine treatment of rapidcycling bipolar disorder: an open prospective study.
    58. (2004). Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania.
    59. (2004). Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomised, doubleblind, placebo-controlled study. Bipolar Disord,
    60. (2003). Recent developments in the treatment of bipolar disorders. Expert Opin Investig Drugs,
    61. (1999). Receptor pharmacology of neuroleptics:relation to clinical effects.
    62. (1999). Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antoipsychotic Seroquel (quetiapine fumarate).
    63. (2000). Review of quetiapine side-effects.
    64. (2000). Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment. Prog Neuropsychopharmacol Biol Psychiatry,
    65. (2002). The differential effect of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition:a pharmacological analysis in rats.
    66. (2001). The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.
    67. (2000). The nature of bipolar disorder.
    68. (1998). The role of complex combination therapy in the treatment of refractory bipolar illness.
    69. (2005). The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
    70. (2001). The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder.Preliminary findings. Arch Gen Psychiatry,
    71. (2002). The safety and pharmacokinetics of quetiapine when co-administered with haloperidol, risperidone, or thioridazine.
    72. (2005). Treatment of acute mania from clinical trials to recommendations for clinical practice. Hum Psychopharmacol,
    73. (2003). Ziprasidone in the treatment of acute bipolar mania:a three-week, placebo-controlled, double blind, randomized trial.
    74. (2001). Ziprasidone:a novel antipsychotic agent with a unique human receptor binding profile.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.